Please see below for useful resources
Regulatory - General Pharmaceutical Council (GPhC) COVID-19 vaccination information/guidance/FAQs
Guidance for those involved in the COVID-19 vaccination programme. Covering information on assurance and governance to ensure safety and accountability.
Indemnity arrangements for COVID-19 vaccination programme
NHSE&I, DHSC, and NHS Resolution have issued a joint letter about the indemnity arrangements that are in place to cover the COVID-19 vaccination programme, which includes community pharmacy.
NPA COVID-19 vaccination training
Information on the suitability and content of this 2 hour virtual training session and additional COVID-19 training resources. From this page you can also link to details of our full vaccination training which includes COVID specific vaccination information.
JCVI issues interim advice on Phase 2 of COVID-19 vaccination programme rollout
The Joint Committee on Vaccination and Immunisation (JCVI) has considered the evidence for Phase 2 of the UK’s COVID-19 vaccination programme
COVID-19 vaccine hesitancy
Information and guidance on providing support to patients/staff who have COVID-19 vaccine hesitancy
AstraZeneca COVID-19 vaccine and blood clots – updated advice issued by JCVI and MHRA
JCVI and MHRA have updated their information on the AstraZenaca COVID-19 vaccine and the extremely rare and unlikely link with blood clots. Updated advice for pharmacy teams
Joint Committee on Vaccination and Immunisation (JCVI) has issued advice to the UK government on the use of the coronavirus (COVID-19) Oxford/AstraZeneca vaccine for people aged under 40